the nf- b/rel family
DESCRIPTION
The NF- B/Rel family. The NF- B/Rel family. A family of signal-responsive transcription factors rapid response som ikke requires proteinsyntese Involved in proinflammatory response: a first line of defense against infectious diseases and cellular stress - PowerPoint PPT PresentationTRANSCRIPT
The NF-B/Rel family
MBV4230
Odd S. Gabrielsen
The NF-B/Rel family
A family of signal-responsive transcription factors rapid response som ikke requires proteinsyntese
Involved in proinflammatory response: a first line of defense against infectious diseases and cellular stress Signal Activated NF-B immune defence activated
Immune response, inflammatory response, accute phase response NFkB also a major anti-apoptopic factor
aberrant activation of NF-B = one of the primary causes of a wide range of human diseases like in Inflammatory diseases, Rheumatoid arthritis, Asthma, Atherosclerosis, Alzheimer
Persistent activated in many cancers - help keeping them alive NFkB also promoting growth
Activated NF-B cyclin D expression enhanced growth Drug against NFkB = putative anti-cancer drug
MBV4230
Odd S. Gabrielsen
The NF-B/Rel family
Characteristic feature: homo- and heterodimeric TFs, which in non-stimulated cells are found inactive in the cytoplasm [in a complex with IB-repressors]. Active DNA-binding form: Dimers with different members of the NF-B/Rel family Inactive cytoplasmic form: inhibitory factor/domain in addition
Upon stimulation, active NF-B rapidly translocates to the nucleus where it binds B-sites and activates target genes.
Rapid response - minutes Signal Activated NF-B immune defence activated
MBV4230
Odd S. Gabrielsen
Signal transduction pathway
Cytoplasminactive
Nucleusactive
Signals
NF-B/Rel proteins
MBV4230
Odd S. Gabrielsen
Common DBD: Rel-homology domain (RHD) RHD: 300aa conserved domain with several
functions DNA-binding (N-terminal half) dimerization (C-terminal half) IB-interaction (C-terminal half) NLS (C-terminal half) kalles også NRD (=NF-kB, Rel, Dorsal)
Spec.DNA-binding dimerizationIkB-interaction
NLS
MBV4230
Odd S. Gabrielsen
Homo- and heterodimers
NF-B/Rel proteins = Homo- and hetero-dimeric TFs that in resting cells are retained in the cytoplasm in complex with IB.
Mature B-cells: constitutively nuclear activator Bound to kappa
immunoglobuline light-chain enhancer its name
MBV4230
Odd S. Gabrielsen
Two main classes of RHDs Rel with TAD (dimeric with ≥ 1 Rel-monomers which are potent
transactivators) synthesized in their mature form Rel or c-Rel (as well as v-Rel) RelA (p65) RelB Drosophilas dorsal and Dif
p50/52 without TAD (homodimers with no transactivation properties) synthesized as precursors that are processed Precursor forms have internal IB inhibitor function
RHD linked to inhibitory domain through Gly-rich linker (protease sensitive) Blocks DNA-binding and translocation to nucleus
p105 undergoes proteolytic maturation to p50 [NF-B1] Proteolytic degradation to p50 is signal dependent, requires ATP and occurs through a
ubiquitin-dependent proteasome pathway Also transcription from an intronic promoter expressionof IkB-
p100 undergoes proteolytic maturation to p52 [NF-B2] p50/52 are distinct gene products with very similar properties
MBV4230
Odd S. Gabrielsen
Two main classes of RHDs
p105
p50
p100
p52
RelA(p65)
cRel
RelB
Rel homology domain
C-terminal IB-like domains
Acitvation domains+TAD
- TAD
MBV4230
Odd S. Gabrielsen
RHD proteins
Ankyrinrepeats
RHD
MBV4230
Odd S. Gabrielsen
Dimer-formation
Dimer-formation necessary for DNA-binding each subunit interacts with one half site B-sites symmetric: 5´-GGGRNNYYCC-3´
Most combinations allowed Different heterodimers vary with respect to
preference for different kB-seter Kinetics of nuclear translocation
p50/p65 rapid, p50/Rel slow abundance in different cells
Exception: RelB which forms dimer only with p50/p52 Common form: p50/p65 (NF-kB1/RelA)
most abundant, found in most cells
–--5´-GGGRNNYYCC-3´--–- 3´-CCCYNNRRGG-5´--
MBV4230
Odd S. Gabrielsen
3D structure - DNA interaction
Crystal structures: p50-p50-DNA and p50-p65-DNA
Two distinct domains 1. N-terminal - specific DNA contact
Compact core in the form of an antiparalell -barrel from which loops protrude
The loop between AB = recognition loop with base contacts in major groove
Critical for specificity = R57-R59-E63 C62 responsible for redox-sensitivity
2. C-terminal domain responsible for dimerisation + nonspecific DNA-phosphate contact
Conserved interphase explains why most heterodimers are possible
N-terminaldomain
C-terminaldomain
MBV4230
Odd S. Gabrielsen
Structure: NFB (p50-p65) + DNA
Side view
• -barrel core with protrding loops • The AB loop = recognition loop• Specificity R57-R59-E63• C62 redox-sensitivity
MBV4230
Odd S. Gabrielsen
3D structure - DNA interaction
Characteristic features of DNA-interaction Each monomer contacts a separate half site “Closing jaws” mechanism for DNA-binding
The protein encloses DNA Unusual strong binding (Kd = 10-12 M) Dissociation requires opening of the jaws through a flexible
linker
MBV4230
Odd S. Gabrielsen
3D structure - protein interaction
Interaction with HMGI(Y) IFN- promoter: HMGI(Y) binds AT-rich centre of B-sites in minor groove The structure contains a corresponding open space
Interaction with IB IB binding in an opening over the dimer-interphase IB binding blocks DNA-binding
due to steric effect ? due to hinge-effect ? due to induced change of geometry in C-terminal domain reduced non-specific
DNA-binding?
The I-B family
MBV4230
Odd S. Gabrielsen
The I-B proteins
N-terminal Regulatory domain
Ankyrinrepeats
MBV4230
Odd S. Gabrielsen
The IB-family
Inhibitory function impedes DNA-binding blocks NLS and abolish translocation to nucleus
Several members (at least 7 mammalian) IB- and IB- IB-and IB- Bcl-3 p105 and p110 IkBR
Common features: ankyrin-repeats which are necessary for RHD-interaction
30-33 aa motif repeated 3 - 7x C-terminal acidic-region necessary for inhibition of DNA-binding C-terminal PEST-sequence involved in protein-degradation
SpecificityEx. IkB- inhibits DNA-binding of p65/p50 but not of p50/p50
MBV4230
Odd S. Gabrielsen
NFB-IB complex
IkB
HMGI(Y)
MBV4230
Odd S. Gabrielsen
Signaling
The chain of events in the canonical NFB signaling pathway
MBV4230
Odd S. Gabrielsen
Cytoplasmic retention due to interaction with IB-family proteins Two types of inactive complexes in the cytoplasm
1. Trimers = RHD-Homo-or heterodimers bound to an IB-repressor 2. Heterodimers = Rel-protein + unprocessed RHD-precursor (p105, p110)
Model: Signal dissociation (?) and degradation Induction signal phosphorylation of both IB and p105 IB degradation or p105
processering active dimers that are translocated to the nucleus. One type of signal two N-terminal serines (S32 and S36) become phosphorylated Another type of signal two C-terminal serines become phosphorylated in p105 phosphorylation probably more a signal for degradation than for dissociation
Ubiquitin-pathway involved Stimulation rapid degradation of IB
complete after 10 min No traces of IB
phosphorylation of IB multiubiquitylation in K21, K22 degradation through a ubiquitin-dependent proteasome pathway
I presence of proteasome-inhibitors phosphorylated IkB remains associated with NFkB
MBV4230
Odd S. Gabrielsen
Several IB-factors with different properties IB-: Rapid transient response
IB- best characterized all stimuli degradation of IB- ex: TNF-rapid and transient activation of NF-kB
IB-: Sustained response Only certain stimuli degradation of IB- ex: LPS or IL-1degradation of both IB-and IB- activation of NF-
kB lasting for hours Bcl-3: repressor and activator
inhibits certain complexes like a normal IB But may also associate with DNA-bound p50 and p52 dimers (lacking TAD)
and provide transactivation properties
Signaling pathways
MBV4230
Odd S. Gabrielsen
Upstream and downstream
NF-kB
Signal transductionpathways
+ +..
+ ..
Upstream
Downstream
MBV4230
Odd S. Gabrielsen
Signaling
The chain of events in the NFB signaling pathway
The system = a total of 50 gene-products, but only 1 component is regulated: the IKK complex
MBV4230
Odd S. Gabrielsen
Multiple signalling pathways activate NF-B
Several signalling pathways converge by activation of NF-B NF-B respond to a broad range of different stimuli
Virus infection (HIV, hepatite B), virus proteins (tax, E1A) and dsRNA
Cytokines (TNF, IL-1 and IL-2) Bacterial LPS stimulation of antigen reseptor on B- and T-cells calcium ionophores protein synthesis inhibitors UV and X-ray sphingomylenase/ceramide phorbol esters nitrogen oxide
MBV4230
Odd S. Gabrielsen
One type of signaling hits I-B through phosphorylation
Two N-terminal serines becomes phosphorylated TNF-signalling pathways: TNF-receptor
TRADD/TRAF NIK IKK IB
IB-kinase complex central in the signaling pathway A large 500-900 kDa IKK (IB-kinase)
complex that is induced by cytokines Two key subunits: IKK and IKK
Each with three domains: KD (kinase domain) + LZ (leucine zipper) + HLH (helix-loop-helix)
?Kinase?
MBV4230
Odd S. Gabrielsen
The IB-kinase complex central in the pathway
IB-kinase complex
MBV4230
Odd S. Gabrielsen
The IKK-kinase becomes activated through phosphorylation
Activation loop in IKK Two serines bocomes phosphorylated
in a signal dep manner (IL1, TNF) Ala-mutants block the signalling
pathway, Glu-mutants lead to a constitutive active kinase
Signal phosphorylation phosphorylation of loop necessary for
NFB-activation of cytokines Attenuation
phosphorylated activation loop altered HLH-kinase domain interaction reduced kinase-aktivitet
Ser-OH
Ser-OH
Ser-P
Ser-P
SignalUpstream kinase
inactive active
IKKß
IB
inactiveP P
PP
Autophosphorylation
MBV4230
Odd S. Gabrielsen
Stimulus-specific signal transduction pathways?
MBV4230
Odd S. Gabrielsen
Stimulus-specific signalling pathways?
Novel IKK-candidates IKK possibly the kinase in an
independent IKK-complex which is responsive to phorbol esters (PMA/TPA) and T-cell receptor, but not to TNF and IL1.
Possibly more Novel IKK-kinase
candidates Upstream cascade from
membrane-receptors to the IKK-complex where TRAF and NIK are involved
Alternative inputs probably through MEKK1 and Akt/PKB
AlternativeIKK-kinases
AlternativeIKK-complexes
Signal 1
Signal 2
Signal 3
MBV4230
Odd S. Gabrielsen
Why two kinases?
Ser-OH
Ser-OH
Ser-P
Ser-P
Signalupstream kinase
inactive active
IKKß
IB
In vitro: IKK ≈ IKK 52% identity Similar kinase activity
In vivo: IKK ≠ IKK Ala-mutants of IKKß NFB
response dead Glu-mutants of IKKß NFB
response independent of signals Ala-mutants of IKKNFB
response unaffected Glu-mutants of IKKNFB
response unaffected Is IKK totally unlinked
to NFB?
MBV4230
Odd S. Gabrielsen
The next indication: KO phenotypes of IKK ≠ IKK
Knock-out of of IKKloss of B- and T-cell response Normal development Mice dead at day 13.5, liver destroyed due to massive apoptosis Lack of IKK lack of active NFkB lack of protection against apoptosis
massive cell death Lost T-cell response because Apoptosis important for T-cell development
Knock-out of of IKK , epidermis 5-10x thicker than normal, highly
undifferentiated sl Normal number of B- and T-cells, but B-cells not fully differentiated
MBV4230
Odd S. Gabrielsen
A separate signaling pathway through IKK A desparate postdoc looked at all the 50
components - all behaved normal, except one The proteolytic maturation of the p100
precursor to p52 [NF-B2] was defective in the IKK
processing depends on NIK Hypothesis: NIK acts through IKK
MBV4230
Odd S. Gabrielsen
The solution Processing dependson IKK
Target ofIKK
MBV4230
Odd S. Gabrielsen
Model - two divergent pathways through the IKK complex
TNF-R
Altered processingof p100
NIK
Signal 2
Affect B-cellmaturation
A role in adaptive immunity
A role in innate immunity
MBV4230
Odd S. Gabrielsen
Two kinases- two main signaling pathways
The canonical NF-B activation pathway (left) Applies to RelA-p50 and c-Rel-p50 Retained in cytoplasm by IB Triggered by microbial and viral
infections and exposure to proinflammatory cytokines
Depends mainly on the IKK subunit of the IKK complex.
The second pathway (right) Affects NF-B2, which preferentially
dimerizes with RELB. Triggered by members of the tumour-
necrosis factor (TNF) cytokine family Depends selectively on activation of the
IKK subunit + another kinase NIK. Induce the phosphorylation-dependent
proteolytic removal of the IB-like C-terminal domain of NF-B2.
Target genes
MBV4230
Odd S. Gabrielsen
Upstream and downstream
NF-kB
Signal transductionpathways
+ +..
+ ..
Upstream
Downstream
MBV4230
Odd S. Gabrielsen
Families of target genes
Immune response Cytokines, Chemokines Cytokine and immuno-receptors Adhesion molecules Acute-phase proteins Stress-responsive genes
NF-B is both being activated by and inducing the expression of inflammatory cytokinesNF-B activation can spread from cell to cell
MBV4230
Odd S. Gabrielsen
Negative feedback:Attenuation of respons Negative loop: IB- under direct control of NF-B
Activated NF-B translocated to the nucleus will activate expression of IB- Newly synthesized IB-will bind up and inactivate remaining NF-B in the
cytoplasma Excess IB-will migrate to the nucleus and inactivate DNA-bound NF-B
(contains both NLS and nuclear eksport signal) A20 protein another strongly induced negative feedback protein
Immunosupressive effect of glucocorticoids Probably a direct effect of glucocorticoids enhancing the expression of IB-
which then binds up and inactivates NF-B in the cytoplasm, leading to reduced immune- and inflammatory response
MBV4230
Odd S. Gabrielsen
Target genes:Link to cancer Tumorigenesis requires
6 types of alterations Hanahan & Weinberg 2000
Several of these can be caused by perturbation in NF-B or linked signaling molecules Tumour cells in which NF-B is
constitutively active are highly resistant to anticancer drugs or ionizing radiation.
AngiogenesisMetastasis
Disease links
MBV4230
Odd S. Gabrielsen
Viruses exploit NF-B
several patogenic viruses exploit the NF-B system for their own profit Incorporation of B-sites in virus DNA cause enhanced expression of
virus-genes when the immune response is activated Virus proteins activate NF-B
MBV4230
Odd S. Gabrielsen
Disease links
MBV4230
Odd S. Gabrielsen
Constitutivelynuclear NF-B
Disruption of the regulatory mechanism aberrant activation of NFB = one of the primary causes of a wide range of human diseases Inflammatory diseases
Rheumatoid arthritis Asthma
Atherosclerosis Alzheimer
MBV4230
Odd S. Gabrielsen
Link: inflammation - cancer
A causal connection between inflammation and cancer has been suspected for many years.
NF-B might serve as the missing link between these two processes. NF-B becomes activated in response to inflammatory stimuli Constitutive activation of NF-B has been associated with cancer,
MBV4230
Odd S. Gabrielsen
Mechanisms of NF-B activation promoting leukemia
Mechanisms by which NF-B activation can contribute to leukaemia and lymphogenesis 1. Input: NF-B can be constitutively activated in
myeloid and lymphoid cells in response to growth factors and cytokines or the expression of certain viral oncoproteins.
2. Gene errors: Persistent NF-B activation can also be brought about by chromosomal rearrangements that affect genes that encode NF-B or I-B.
3. Autocrine loop: Once NF-B is activated, it can lead to the production of cytokines and growth factors, such as CD40 ligand (CD40L), that further propagates its activation.
4. Growth - apoptosis: It also activates the transcription of cell-cycle regulators, such as cyclins D1 and D2, which promote G1- to S-phase transition, or inhibitors of apoptosis, such as BCL-XL, cIAPs and A1/BFL1.
1. 2.
3.4.
Tumour cells in which NF-B is constitutively active are highly resistant to anticancer drugs or ionizing radiation.
MBV4230
Odd S. Gabrielsen
Breast cancer: Signalling pathways that stimulate proliferation
Signaling induction of cyclin D1. Two signalling pathways contribute to the induction of cyclin
D1 transcription in mammary epithelial cells. One pathway, which leads to activation of transcription factor
AP1, is activated by growth factors (GF), which bind to receptor tyrosine kinases (RTK). This pathway relies on activation of RAS and MAPK cascades.
The second pathway is activated by the TNF-family receptor activator of NF-B ligand (RANKL), which binds to the receptor activator of NF-B (RANK). This pathway, which leads to activation of NF-B, depends on the IKK subunit of the IKK complex.
After nuclear translocation, NF-B activates cyclin D1 expression, leading to cell-cycle progression. The expression of GFs and RANKL is regulated by various
hormonal stimuli during mammary-gland development. Aberrant and persistent activation of either pathway can lead to deregulated proliferation of mammary epithelial cells.
MBV4230
Odd S. Gabrielsen
Blocking the response
Redox-dependency Antioxidants and alkylating agens inhibit response to many stimuli and
inhibit phosphorylation and degradation of IB H2O2 activates NF-B Induction of ROI (reactive oxygen intermediates) a possible common
element?
Proteasome inhibitors
MBV4230
Odd S. Gabrielsen
Therapeutic inhibition of NFB Numerous
inhibitors of NF-B under development.
Difficult to develop cancer specific inhibitors.
Understanding the two pathways should lead to better therapeutics.